Latest filing published 09 Jun 2025 for Cytek Biosciences, Inc..
Insider track record
No signal scores available.
Don M. Hardison: trading record in brief
This profile gathers the share dealings of Don M. Hardison across 3 companies, led by Labcorp Holdings Inc., HTG Molecular Diagnostics, Inc and Cytek Biosciences, Inc. In total, 14 filings cover trades dated from 4 September 2007 to 5 June 2025.
On the market, this insider has only sold: 2 sales, €106k in total. Other entries cover 11 share grants and 1 option exercise.
The latest filing, published on 9 June 2025, reports an option exercise in Cytek Biosciences, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Don M. Hardison
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,706 sharesCommon StockSEC:0001415889-25-016316:0
- 2,500 shares0Common StockSEC:0001209191-19-046327:0
- 2,500 shares0Common StockSEC:0001209191-18-047485:0
- 7,500 shares@ US$2.05100.0% of flowCommon StockSEC:0001209191-17-050160:0
- 3,848 shares@ US$74.84Common StockSEC:0001225208-10-001673:0
- 854 shares@ US$69.50Common StockSEC:0001225208-09-017529:0
- 1,407 shares@ US$61.73Common StockSEC:0001225208-09-012797:0
- 1,353 shares@ US$62.51Common StockSEC:0001225208-09-004650:0
- 858 shares@ US$62.42Common StockSEC:0001225208-09-003915:0
- 9,400 shares0Common StockSEC:0001225208-09-003665:0
- 1,352 shares@ US$80.41Common StockSEC:0000920148-08-000062:0
- 7,700 shares0Common StockSEC:0000920148-08-000048:0
- 12,500 shares0Common StockSEC:0000920148-07-000219:0
13 of 13 declarations
